Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Reyon Pharmaceutical Co Ltd

+ Add to Watchlist

102460:KS

24,650 KRW 350 1.40%

As of 23:55:44 ET on 05/06/2015.

Snapshot for Reyon Pharmaceutical Co Ltd (102460)

Open: 25,000 Day's Range: 24,000 - 25,500 Volume: 51,944
Previous Close: 25,000 52wk Range: 18,100 - 33,000 1-Yr Rtn: +33.07%

Stock Chart for 102460

No chart data available.
  • 102460:KS 24,650
  • 1D
  • 1M
  • 1Y
25,000
Interactive 102460 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 102460

Current P/E Ratio (ttm) 27.4194
Estimated P/E(-) -
Relative P/E vs. KOSPI 1.4236
Earnings Per Share (ttm) 899.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 317,985.00
Shares Outstanding (M) 12.90
30 Day Average Volume 134,252
Price/Book (mrq) 2.0448
Price/Sale (ttm) 2.8363
Dividend Indicated Gross Yield 1.01%
Cash Dividend (KRW) 250.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth -
Next Earnings Announcement 05/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 102460

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 102460

Reyon Pharmaceutical Co., Ltd. produces over the count drug and raw materials for drug. The products include antibiotics, antiphlogistic, and generic drugs.

Jeong Soon-OkVice ChairmanPark Soo-ChunPresident/Rep Director/CEO
Ha Sun-BongVice PresidentJang Chung-WoongVice President
More Company Profile & Key Executives for 102460

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil